Comparing artificial intelligence algorithms to 157 German dermatologists: the melanoma classification benchmark (2019) Brinker TJ, Hekler A, Hauschild A, Berking C, Schilling B, Enk AH, Haferkamp S, et al. Journal article Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases (2019) Rauschenberg R, Bruns J, Bruetting J, Daubner D, Lohaus F, Zimmer L, Forschner A, et al. Journal article Sequence-dependent cross-resistance of combined radiotherapy plus BRAF(V600E) inhibition in melanoma (2019) Shannan B, Matschke J, Chauvistre H, Vogel F, Klein D, Meier F, Westphal D, et al. Journal article Pathologist-level classification of histopathological melanoma images with deep neural networks. (2019) Hekler A, Utikal JS, Enk AH, Klode J, Schadendorf D, Jansen P, Franklin C, et al. Journal article Superior skin cancer classification by the combination of human and artificial intelligence. (2019) Hekler A, Utikal JS, Enk AH, Hauschild A, Weichenthal M, Maron RC, Berking C, et al. Journal article Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task. (2019) Brinker TJ, Hekler A, Enk AH, Klode J, Hauschild A, Berking C, Schilling B, et al. Journal article A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task. (2019) Brinker TJ, Hekler A, Enk AH, Klode J, Hauschild A, Berking C, Schilling B, et al. Journal article Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective data (vol 119, pg 30, 2019) (2019) Sondermann W, Utikal JS, Enk AH, Schadendorf D, Klode J, Hauschild A, Weichenthal M, et al. Journal article, Erratum Corrigendum to ‘Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective data’ [Eur J Cancer, 119 (September 2019) Pages 30–34](S0959804919304095)(10.1016/j.ejca.2019.07.009) (2019) Sondermann W, Utikal JS, Enk AH, Schadendorf D, Klode J, Hauschild A, Weichenthal M, et al. Journal article, Erratum Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto—GBG 84): A randomised phase III trial (2019) Schneeweiss A, Moebus V, Tesch H, Hanusch C, Denkert C, Luebbe K, Huober J, et al. Journal article